OBJECTIVES: To investigate the extent to which self-reported mobility deficit in the absence of impairment in activities of daily living (ADL) is associated with elevated mortality risk. DESIGN: Prospective cohort study, with annual assessments of mobility and ADL status and ongoing monitoring of vital status. SETTING: Population-based cohort drawn from Medicare enrollees in New York City. PARTICIPANTS: One thousand two hundred ninety-eight older adults reporting functional status at baseline (1992-1994) and 2 years later. MEASUREMENTS: Subjects reported mobility (e.g., walking, climbing stairs, and rising from a chair) and ADL (e.g., bathing, toilet use, dressing, grooming, and feeding) limitations. Two-year functional status trajectories were noted. We used two additional follow-up periods, at 2 and 4 years, to examine the likelihood that older people with mobility deficit may face an increased risk of death without first passing through a state of enduring ADL disability. RESULTS: At 2 years, 12.7% had incident mobility deficit without ADL disability, and 21.3% were persistently disabled in mobility without ADL disability. Relative to subjects free of disability at baseline and follow-up, risk of mortality in the incident mobility deficit group was elevated at 2 and 4 years but did not achieve statistical significance. By contrast, for subjects with persistent mobility impairment who did not report ADL impairment, the mortality risk was significantly elevated both at 2 years (relative risk (RR) = 2.5; 95% confidence interval (CI) = 1.1-5.7)) and 4 years (RR = 2.9; 95% CI = 1.7-4.9)) of follow-up. Mortality was significantly elevated in this group in analyses restricted to respondents with no or only one comorbid condition. CONCLUSION: Continuing, self-reported mobility impairment in the absence of ADL deficit is a risk factor for mortality. Older people with self-reported mobility deficit face an increased risk of mortality without first passing through enduring states of ADL disability.
OBJECTIVES: To investigate the extent to which self-reported mobility deficit in the absence of impairment in activities of daily living (ADL) is associated with elevated mortality risk. DESIGN: Prospective cohort study, with annual assessments of mobility and ADL status and ongoing monitoring of vital status. SETTING: Population-based cohort drawn from Medicare enrollees in New York City. PARTICIPANTS: One thousand two hundred ninety-eight older adults reporting functional status at baseline (1992-1994) and 2 years later. MEASUREMENTS: Subjects reported mobility (e.g., walking, climbing stairs, and rising from a chair) and ADL (e.g., bathing, toilet use, dressing, grooming, and feeding) limitations. Two-year functional status trajectories were noted. We used two additional follow-up periods, at 2 and 4 years, to examine the likelihood that older people with mobility deficit may face an increased risk of death without first passing through a state of enduring ADL disability. RESULTS: At 2 years, 12.7% had incident mobility deficit without ADL disability, and 21.3% were persistently disabled in mobility without ADL disability. Relative to subjects free of disability at baseline and follow-up, risk of mortality in the incident mobility deficit group was elevated at 2 and 4 years but did not achieve statistical significance. By contrast, for subjects with persistent mobility impairment who did not report ADL impairment, the mortality risk was significantly elevated both at 2 years (relative risk (RR) = 2.5; 95% confidence interval (CI) = 1.1-5.7)) and 4 years (RR = 2.9; 95% CI = 1.7-4.9)) of follow-up. Mortality was significantly elevated in this group in analyses restricted to respondents with no or only one comorbid condition. CONCLUSION: Continuing, self-reported mobility impairment in the absence of ADL deficit is a risk factor for mortality. Older people with self-reported mobility deficit face an increased risk of mortality without first passing through enduring states of ADL disability.
Authors: Michelle C Odden; Kenneth E Covinsky; John M Neuhaus; Elizabeth R Mayeda; Carmen A Peralta; Mary N Haan Journal: J Gerontol A Biol Sci Med Sci Date: 2012-03-01 Impact factor: 6.053
Authors: June R Lunney; Steven M Albert; Robert Boudreau; Diane Ives; Suzanne Satterfield; Anne B Newman; Tamara Harris Journal: J Gen Intern Med Date: 2017-12-04 Impact factor: 5.128
Authors: Marco Pahor; Jack M Guralnik; Walter T Ambrosius; Steven Blair; Denise E Bonds; Timothy S Church; Mark A Espeland; Roger A Fielding; Thomas M Gill; Erik J Groessl; Abby C King; Stephen B Kritchevsky; Todd M Manini; Mary M McDermott; Michael E Miller; Anne B Newman; W Jack Rejeski; Kaycee M Sink; Jeff D Williamson Journal: JAMA Date: 2014-06-18 Impact factor: 56.272
Authors: Carolien L van den Brink; Marja Tijhuis; Geertrudis A M van den Bos; Simona Giampaoli; Aulikki Nissinen; Daan Kromhout Journal: Am J Public Health Date: 2005-09-29 Impact factor: 9.308
Authors: Raj C Shah; Aron S Buchman; Patricia A Boyle; Sue E Leurgans; Robert S Wilson; Gunnar B Andersson; David A Bennett Journal: J Gerontol A Biol Sci Med Sci Date: 2010-10-21 Impact factor: 6.053
Authors: Todd M Manini; Daniel P Beavers; Marco Pahor; Jack M Guralnik; Bonnie Spring; Timothy S Church; Abby C King; Sara C Folta; Nancy W Glynn; Anthony P Marsh; Thomas M Gill Journal: J Am Geriatr Soc Date: 2017-02-07 Impact factor: 5.562
Authors: Roger A Fielding; W Jack Rejeski; Steven Blair; Tim Church; Mark A Espeland; Thomas M Gill; Jack M Guralnik; Fang-Chi Hsu; Jeffrey Katula; Abby C King; Stephen B Kritchevsky; Mary M McDermott; Michael E Miller; Susan Nayfield; Anne B Newman; Jeff D Williamson; Denise Bonds; Sergei Romashkan; Evan Hadley; Marco Pahor Journal: J Gerontol A Biol Sci Med Sci Date: 2011-08-08 Impact factor: 6.053